David H. Chung

David H. Chung

Keine laufenden Positionen mehr

Health Technology
Consumer Services
Distribution Services

Ursprung des Netzwerks ersten Grades von David H. Chung

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von David H. Chung

UnternehmenSektorVerknüpfte PersonenHauptposition
BELUGA COMPOSITES CORP. Medical Specialties

James Welch

Director of Finance/CFO

Drew University College/University

Meera Desai

Undergraduate Degree

NEKTAR THERAPEUTICS Pharmaceuticals: Major

Meera Desai

Corporate Officer/Principal

VIVUS, INC. Pharmaceuticals: Major

Timothy Morris

Director of Finance/CFO

RIGEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

James Welch

Director of Finance/CFO

CUTERA, INC. Medical Specialties

Guy Nohra

Director/Board Member

Pharmaceuticals: Major

Mike A. Royal

Chief Tech/Sci/R&D Officer

Semiconductors

James Welch

Corporate Officer/Principal

MEDISUN PRECISION MEDICINE LTD. Biotechnology

William Callahan

Director/Board Member

Medical/Nursing Services

Mike A. Royal

Corporate Officer/Principal

Wake Forest University College/University

Richard Afable

Corporate Officer/Principal

Iowa State University College/University

Meera Desai

Doctorate Degree

Massachusetts Institute of Technology College/University

Mike A. Royal

Undergraduate Degree

California State University-Chico College/University

Timothy Morris

Undergraduate Degree

Chapman University College/University

Richard Afable

Director/Board Member

College/University

Richard Afable

Corporate Officer/Principal

Loyola University of Chicago College/University

Richard Afable

Doctorate Degree

San Francisco State University College/University

William Callahan

Undergraduate Degree

University of Illinois College/University

Richard Afable

Graduate Degree

Washington State University College/University

James Welch

Masters Business Admin

CADENCE PHARMACEUTICALS, INC. Pharmaceuticals: Major

Mike A. Royal

Corporate Officer/Principal

DBV TECHNOLOGIES Pharmaceuticals: Major

Timothy Morris

Director/Board Member

Investment Trusts/Mutual Funds

Richard Afable

Chief Executive Officer

Hospital/Nursing Management

Richard Afable

Chief Executive Officer

Pharmaceuticals: Major

Meera Desai

Corporate Officer/Principal

Uniformed Services University of the Health Sciences College/University

Mike A. Royal

Corporate Officer/Principal

Miscellaneous Commercial Services

Richard Afable

Chairman

DMK PHARMACEUTICALS CORPORATION Pharmaceuticals: Major

Meera Desai

Director/Board Member

SORRENTO THERAPEUTICS, INC. Biotechnology

Mike A. Royal

Chief Tech/Sci/R&D Officer

Providence Little Co. of Mary Medical Institute

Richard Afable

Director/Board Member

UMass Chan Medical School College/University

Mike A. Royal

Graduate Degree

The University of Maryland Francis King Carey School of Law College/University

Mike A. Royal

Graduate Degree

Biotechnology

Meera Desai

Director/Board Member

EIGER BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

James Welch

Director of Finance/CFO

St. Joseph Hoag Health

Richard Afable

Chief Executive Officer

Miscellaneous Commercial Services

Richard Afable

Chief Executive Officer

Packaged Software

Mike A. Royal

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mike A. Royal

Chief Tech/Sci/R&D Officer

Medical Specialties

Richard Afable

Director/Board Member

Karana Biotech LLC

Meera Desai

Founder

Hospital/Nursing Management

Richard Afable

Chief Executive Officer

Statistik

International

Vereinigte Staaten 47
Kanada 2
Frankreich 2
China 2

Sektoral

Health Technology 24
Consumer Services 14
Health Services 5
Technology Services 3
Commercial Services 3

Operativ

Director/Board Member 37
Director of Finance/CFO 18
Corporate Officer/Principal 18
Independent Dir/Board Member 10
Chief Tech/Sci/R&D Officer 8
  1. Börse
  2. Insiders
  3. David H. Chung
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT